Manager × security

DE BURLO GROUP INC VRTX holdings history

Who else holds this security? →

VERTEX PHARMACEUTICALS INC · CUSIP 92532F100 · CIK 1134288

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Log in to see them.
Citable facts

As of Sep 30, 2026, DE BURLO GROUP INC reported 4.78K VRTX (shares), valued at $2.50M, or 0.44% of its reported non-derivative portfolio. Filed Nov 5, 2026.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
0.44%
Shares
4.78K
4,780
Reported value
$2.50M
USD

Shares increased 0.84%; reported value increased 6.14%, and weight changed +0.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q3 20260.44%4,780SEC filing ↗Filed Nov 5, 2026
Q2 20260.43%4,740SEC filing ↗Filed Aug 13, 2026
Q1 20260.48%4,755SEC filing ↗Filed May 14, 2026
Q4 20250.26%4,785SEC filing ↗Filed Feb 13, 2026
Q3 20250.24%5,025SEC filing ↗Filed Nov 13, 2025
Q2 20252.86%48,765SEC filing ↗Filed Aug 13, 2025
Q1 20253.49%48,735SEC filing ↗Filed May 7, 2025
Q4 20242.62%48,735SEC filing ↗Filed Feb 14, 2025
Q3 20242.82%49,195SEC filing ↗Filed Nov 12, 2024
Q2 20243.06%48,565SEC filing ↗Filed Aug 14, 2024
Q1 20242.22%40,040SEC filing ↗Filed May 13, 2024
Q4 20233.91%64,765SEC filing ↗Filed Feb 13, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20233.91%64,765$22.52MThe prior quarter is outside the free window. Log in for the comparison.SEC filing ↗
Filed Feb 13, 2024
Q1 20242.22%40,040$16.74MShares decreased 38.18%; reported value decreased 25.68%, and weight changed -1.69 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 13, 2024
Q2 20243.06%48,565$22.76MShares increased 21.29%; reported value increased 36.01%, and weight changed +0.84 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 20242.82%49,195$22.88MShares increased 1.30%; reported value increased 0.51%, and weight changed -0.24 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 12, 2024
Q4 20242.62%48,735$19.63MShares decreased 0.94%; reported value decreased 14.22%, and weight changed -0.20 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20253.49%48,735$23.63MShares unchanged; reported value increased 20.39%, and weight changed +0.87 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 7, 2025
Q2 20252.86%48,765$21.71MShares increased 0.06%; reported value decreased 8.12%, and weight changed -0.63 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2025
Q3 20250.24%5,025$1.97MShares decreased 89.70%; reported value decreased 90.94%, and weight changed -2.62 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 13, 2025
Q4 20250.26%4,785$2.17MShares decreased 4.78%; reported value increased 10.23%, and weight changed +0.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 13, 2026
Q1 20260.48%4,755$2.12MShares decreased 0.63%; reported value decreased 2.12%, and weight changed +0.22 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2026
Q2 20260.43%4,740$2.35MShares decreased 0.32%; reported value increased 10.89%, and weight changed -0.05 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2026
Q3 20260.44%4,780$2.50MShares increased 0.84%; reported value increased 6.14%, and weight changed +0.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 5, 2026
DE BURLO GROUP INC · VERTEX PHARMACEUTICALS INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_institutional_holdings
{"action":"portfolio","cik":"1134288","quarter":"2026Q3","cusip":"92532F100"}

akkru_institutional_holdings
{"action":"history","cik":"1134288","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP / CLI documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.